The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
NCT Number: NCT04950816
The purpose of this study is to conduct a trial of the tailored Mindfulness- Based Intervention (MBI) (.b) vs. attention control to test real-world feasibility and acceptability of this tailored Mindfulness - Based Intervention (MBI) in youth experiencing homelessness (YEH).
Looking for future studies?
Notify Me18 year–25 year
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The session will include brief didactic presentations, videos, and mindfulness practice followed by inquiry. We anticipate that sessions will take place twice a week. Sessions will be held on site at the Covenant House Texas (CHT) shelter in a quiet, designated learning space to ease access to sessions for the participants and to assure access to shelter staff (e.g., social workers and case managers) and services (e.g., food and shelter). CHT has onsite, weekday clinical and mental health care and established protocols for accessing needed resources 24/7. Selection criteria for the interventionist include maintaining a personal mindfulness practice for at least two years, trained in .b, and prior experience working with high-risk youth. The interventionist will receive additional training in Trauma-Informed Care as well as study procedures.
Participants will receive no training in MBI or meditation. Topics covered may include physical activity, nutrition, managing weight, understanding adolescence, personal care, avoiding tobacco, alcohol, and drugs though this will be finalized in YR-1 with the HYWG and advisory panel. The HT program will be led by a positive adult instructor with training in health education or a related field and experience working with YEH.
Time frame: Baseline
The DERS is a 36-item questionnaire, and each item is scored from 1(almost never)-5 (almost always). The 36 items were added to generate a scale from 36 to 180, a higher score indicates greater problem with emotion regulation.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The DERS is a 36-item questionnaire, and each item is scored from 1(almost never)-5 (almost always). The 36 items were added to generate a scale from 36 to 180, a higher score indicates greater problem with emotion regulation.
Time frame: 3 months post intervention
The DERS is a 36-item questionnaire, and each item is scored from 1(almost never)-5 (almost always). The 36 items were added to generate a scale from 36 to 180, a higher score indicates greater problem with emotion regulation.
Time frame: 6 months post intervention
The DERS is a 36-item questionnaire, and each item is scored from 1(almost never)-5 (almost always). The 36 items were added to generate a scale from 36 to 180, a higher score indicates greater problem with emotion regulation.
Time frame: Baseline
The CAMM is a 10 item questionnaire and each item is scored from 0(never true)-4 (always true). The 10 items were added to generate a scale from 0 to 40, a higher score indicates higher levels of mindfulness
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The CAMM is a 10 item questionnaire and each item is scored from 0(never true)-4 (always true). The 10 items were added to generate a scale from 0 to 40, a higher score indicates higher levels of mindfulness
Time frame: 3 months post intervention
The CAMM is a 10 item questionnaire and each item is scored from 0(never true)-4 (always true). The 10 items were added to generate a scale from 0 to 40, a higher score indicates higher levels of mindfulness
Time frame: 6 months post intervention
The CAMM is a 10 item questionnaire and each item is scored from 0(never true)-4 (always true). The 10 items were added to generate a scale from 0 to 40, a higher score indicates higher levels of mindfulness
Time frame: Baseline, immediately after intervention (about 2 to 4 weeks after baseline),3 months post intervention,6 months post intervention
The CAMS-R is a 12-item measure and each item is scored from 1( rarely/not at all)-4(almost always). Higher values reflect greater mindful qualities
Time frame: Baseline
The Self-Compassion Scale (SCS) total score ranges from 1 to 5, higher score indicating greater self compassion..
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The Self-Compassion Scale (SCS) total score ranges from 1 to 5, higher score indicating greater self compassion.
Time frame: 3 months post intervention
The Self-Compassion Scale (SCS) total score ranges from 1 to 5, higher score indicating greater self compassion.
Time frame: 6 months post intervention
The Self-Compassion Scale (SCS) total score ranges from 1 to 5, higher score indicating greater self compassion.
Time frame: Baseline
The PSS is a 10 item questionnaire and each item is scored from 0(never)-4(very often). The 10 items were added to generate a scale from 0 to 40, higher score indicating a higher perceived stress.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The PSS is a 10 item questionnaire and each item is scored from 0(never)-4(very often). The 10 items were added to generate a scale from 0 to 40, higher score indicating a higher perceived stress.
Time frame: 3 months post intervention
The PSS is a 10 item questionnaire and each item is scored from 0(never)-4(very often). The 10 items were added to generate a scale from 0 to 40, higher score indicating a higher perceived stress.
Time frame: 6 months post intervention
The PSS is a 10 item questionnaire and each item is scored from 0(never)-4(very often). The 10 items were added to generate a scale from 0 to 40, higher score indicating a higher perceived stress.
Time frame: Baseline
Percentage of participants who met study eligibility criteria who enroll (provide informed consent) in the study
Time frame: 6 months post intervention
Number of participants who adhere to treatment is measured by the number of participants who attended at least 3 of 5 group sessions.
Time frame: 3 months post intervention
Time frame: 6 months post intervention
Time frame: 6 months post intervention
The Credibility and Expectancy Questionnaire (CEQ) was used to assess the acceptability of the intervention. All participants completed both subscales: the credibility subscale and the expectancy subscale. Each subscale total score ranges from 0 to 10, with higher scores indicating greater perceived acceptability. The expectancy subscale is reported.
Time frame: 6 months post intervention
The Credibility and Expectancy Questionnaire (CEQ) was used to assess the acceptability of the intervention. All participants completed both subscales: the credibility subscale and the expectancy subscale. Each subscale total score ranges from 0 to 10, with higher scores indicating greater perceived acceptability. The credibility subscale is reported.
Time frame: Baseline
The scale is a 8 item questionnaire and each item is scored from 1(strongly disagree)-6(strongly agree). The 8 items were added to generate a scale from, 8 to 48, a higher score indicating more connectedness to others.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The scale is a 8 item questionnaire and each item is scored from 1(strongly disagree)-6(strongly agree). The 8 items were added to generate a scale from, 8 to 48, a higher score indicating more connectedness to others.
Time frame: 3 months post intervention
The scale is a 8 item questionnaire and each item is scored from 1(strongly disagree)-6(strongly agree). The 8 items were added to generate a scale from, 8 to 48, a higher score indicating more connectedness to others.
Time frame: 6 months post intervention
The scale is a 8 item questionnaire and each item is scored from 1(strongly disagree)-6(strongly agree). The 8 items were added to generate a scale from, 8 to 48, a higher score indicating more connectedness to others.
Time frame: Baseline, immediately after intervention (1day after baseline),3 months post intervention,6 months post intervention
The scale is a 13 item questionnaire and each item is scored from 0(not true)-2(true),higher score indicating worse outcome
Time frame: Baseline, immediately after intervention (1day after baseline),3 months post intervention,6 months post intervention
This scale is a 40 item questionnaire, each question is scored from 1(very much so)-4 (not at all), a higher score indicates a worse outcome
Time frame: Baseline
The Psychological Vulnerability Scale is a 6 item questionnaire. Each item is scored from 1 (does not describe me at all) to 5 (describes me very well). The 6 items were added to generate a scale from 6 to 30, a higher score indicates more vulnerability.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The Psychological Vulnerability Scale is a 6 item questionnaire. Each item is scored from 1 (does not describe me at all) to 5 (describes me very well). The 6 items were added to generate a scale from 6 to 30, a higher score indicates more vulnerability.
Time frame: 3 months post intervention
The Psychological Vulnerability Scale is a 6 item questionnaire. Each item is scored from 1 (does not describe me at all) to 5 (describes me very well). The 6 items were added to generate a scale from 6 to 30, a higher score indicates more vulnerability.
Time frame: 6 months post intervention
The Psychological Vulnerability Scale is a 6 item questionnaire. Each item is scored from 1 (does not describe me at all) to 5 (describes me very well). The 6 items were added to generate a scale from 6 to 30, a higher score indicates more vulnerability.
Time frame: Baseline, immediately after intervention (about 2-4 weeks after baseline),3 months post intervention,6 months post intervention
The Balloon Analogue Risk Task (BART) is a computerized measure of risk taking behavior. Each click causes the balloon to incrementally inflate and money to be added to a counter up until some threshold, at which point the balloon is over inflated and explodes. The primary score used to measure BART performance is the adjusted average number of pumps on unexploded balloons, with higher scores indicative of greater risk-taking propensity
Time frame: Baseline, immediately after intervention (1day after baseline),3 months post intervention,6 months post intervention
This is a 10-item questionnaire,each item is scored from 1(none of the time)-5(all of the time) for a total score ranging from 10-50 and a higher score indicating worse outcome
Time frame: Baseline
A single item question was used to assess this outcome. The item asked whether or not you ever had sexual intercourse. The number of participants who answered yes is reported.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
A single item question was used to assess this outcome. The item asked whether or not you ever had sexual intercourse. The number of participants who answered yes is reported.
Time frame: 3 months post intervention
A single item question was used to assess this outcome. The item asked whether or not you ever had sexual intercourse. The number of participants who answered yes is reported.
Time frame: 6 months post intervention
A single item question was used to assess this outcome. The item asked whether or not you ever had sexual intercourse. The number of participants who answered yes is reported.
Time frame: Baseline
A single item question was used to assess this outcome. The item listed various drug substances and asked whether any of those listed had been used in their life. The number of participants who answered yes is reported.
Time frame: Immediately after completing the intervention (about 2 to 4 weeks after baseline)
A single item question was used to assess this outcome. The item listed various drug substances and asked whether any of those listed had been used in their life. The number of participants who answered yes is reported.
Time frame: 3 months post intervention
A single item question was used to assess this outcome. The item listed various drug substances and asked whether any of those listed had been used in their life. The number of participants who answered yes is reported.
Time frame: 6 months post intervention
A single item question was used to assess this outcome. The item listed various drug substances and asked whether any of those listed had been used in their life. The number of participants who answered yes is reported.
Time frame: Baseline
The Patient Health Questionnaire (PHQ-9) is a 9 item questionnaire. Each Item is scored from 0 (not at all) to 3 (nearly every day). The 9 items were added to generate a scale from 0 to 27, with higher scores indicating more severe depression.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The Patient Health Questionnaire (PHQ-9) is a 9 item questionnaire. Each Item is scored from 0 (not at all) to 3 (nearly every day). The 9 items were added to generate a scale from 0 to 27, with higher scores indicating more severe depression.
Time frame: 3 months post intervention
The Patient Health Questionnaire (PHQ-9) is a 9 item questionnaire. Each Item is scored from 0 (not at all) to 3 (nearly every day). The 9 items were added to generate a scale from 0 to 27, with higher scores indicating more severe depression.
Time frame: 6 months post intervention
The Patient Health Questionnaire (PHQ-9) is a 9 item questionnaire. Each Item is scored from 0 (not at all) to 3 (nearly every day). The 9 items were added to generate a scale from 0 to 27, with higher scores indicating more severe depression.
Time frame: Baseline
The Anxiety as Measured by Generalized Anxiety Disorder (GAD) scale is a 7 item questionnaire. Each item is scored from 0 (not at all) to 3 (nearly every day). The 7 items were added to generate a scale from 0 to 21, with higher scores indicating greater severity of symptoms of anxiety.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The Anxiety as Measured by Generalized Anxiety Disorder (GAD) scale is a 7 item questionnaire. Each item is scored from 0 (not at all) to 3 (nearly every day). The 7 items were added to generate a scale from 0 to 21, with higher scores indicating greater severity of symptoms of anxiety.
Time frame: 3 months post intervention
The Anxiety as Measured by Generalized Anxiety Disorder (GAD) scale is a 7 item questionnaire. Each item is scored from 0 (not at all) to 3 (nearly every day). The 7 items were added to generate a scale from 0 to 21, with higher scores indicating greater severity of symptoms of anxiety.
Time frame: 6 months post intervention
The Anxiety as Measured by Generalized Anxiety Disorder (GAD) scale is a 7 item questionnaire. Each item is scored from 0 (not at all) to 3 (nearly every day). The 7 items were added to generate a scale from 0 to 21, with higher scores indicating greater severity of symptoms of anxiety.
Time frame: Baseline
The Promise item bank v.1.0- Emotional Distress 7 item questionnaire includes responses from 1 (never) to 5 (always). Total score ranges from 7 to 35, a higher score indicating higher emotional distress.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The Promise item bank v.1.0- Emotional Distress 7 item questionnaire includes responses from 1 (never) to 5 (always). Total score ranges from 7 to 35, a higher score indicating higher emotional distress.
Time frame: 3 months post intervention
The Promise item bank v.1.0- Emotional Distress 7 item questionnaire includes responses from 1 (never) to 5 (always). Total score ranges from 7 to 35, a higher score indicating higher emotional distress.
Time frame: 6 months post intervention
The Promise item bank v.1.0- Emotional Distress 7 item questionnaire includes responses from 1 (never) to 5 (always). Total score ranges from 7 to 35, a higher score indicating higher emotional distress.
Time frame: Baseline
The Risk Propensity Scale is 7 items and total score ranges from 0 to 100, a higher score indicating greater risk taking.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
The Risk Propensity Scale is 7 items and total score ranges from 0 to 100, a higher score indicating greater risk taking.
Time frame: 3 months post intervention
The Risk Propensity Scale is 7 items and total score ranges from 0 to 100, a higher score indicating greater risk taking.
Time frame: 6 months post intervention
The Risk Propensity Scale is 7 items and total score ranges from 0 to 100, a higher score indicating greater risk taking.
Time frame: Baseline
Executive Function as Measured by the 13 item Amsterdam Executive Function Inventory (AEFI) total score ranges from 1 (true) to 3 (not true), higher score indicates better executive abilities.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
Executive Function as Measured by the 13 item Amsterdam Executive Function Inventory (AEFI) total score ranges from 1 (true) to 3 (not true), higher score indicates better executive abilities.
Time frame: 3 months post intervention
Executive Function as Measured by the 13 item Amsterdam Executive Function Inventory (AEFI) total score ranges from 1 (true) to 3 (not true), higher score indicates better executive abilities.
Time frame: 6 months post intervention
Executive Function as Measured by the 13 item Amsterdam Executive Function Inventory (AEFI) total score ranges from 1 (true) to 3 (not true), higher score indicates better executive abilities.
Time frame: Baseline
PANAS-SF is a 20 item questionnaire, each item is scored from 1(very slightly or not at all)-5(extremely). Positive affect is measured by 10 items (items 1, 3, 5, 9, 10, 12, 14, 16, 17, and 19) score ranges for 10-50 with higher scores indicating higher levels of positive effect. The Positive affect score is reported.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
PANAS-SF is a 20 item questionnaire, each item is scored from 1(very slightly or not at all)-5(extremely). Positive affect is measured by 10 items (items 1, 3, 5, 9, 10, 12, 14, 16, 17, and 19) score ranges for 10-50 with higher scores indicating higher levels of positive effect. The Positive affect score is reported.
Time frame: Baseline
PANAS-SF is a 20 item questionnaire, each item is scored from 1(very slightly or not at all)-5(extremely). Negative affect is measured by 10 items (items 2, 4, 6, 7, 8, 11, 13, 15, 18, and 20) score ranges from 10-50, with lower scores indicating lower levels of negative effect. The negative affect score is reported.
Time frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
PANAS-SF is a 20 item questionnaire, each item is scored from 1(very slightly or not at all)-5(extremely). Negative affect is measured by 10 items (items 2, 4, 6, 7, 8, 11, 13, 15, 18, and 20) score ranges from 10-50, with lower scores indicating lower levels of negative effect. The negative affect score is reported.
The University of Texas Health Science Center, Houston
Other
Examining the Feasibility and Acceptability of a Tailored Version of a Mindfulness-Based Intervention (MBI) Among Youth Experiencing Homelessness (YEH) Aged 18-25 Years Old
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06085105
Adverse Outcomes, Behavior
Navrongo, Ghana
View Trial DetailsNCT04595084
Alcohol Drinking, Alcohol Use, Unspecified
Cambridge, Massachusetts, United States
View Trial DetailsNCT05019131
Adverse Outcomes, Behavior
Migori, Kenya
View Trial DetailsNCT06063174
Behavior, Behavioral Symptoms
Los Angeles, California, United States
View Trial Details